Cargando…

The amyloid beta ion channel hypothesis of Alzheimer’s disease

Alzheimer’s disease (AD) is a leading cause of chronic dementia in the US. Its incidence is increasing with an attendant increase in associated health care costs. Since its first description in a patient by Dr. Alois Alzheimer over a century ago, a large body of biomedical literature has established...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirwany, Najeeb A, Payette, Daniel, Xie, Jun, Guo, Qing
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656296/
https://www.ncbi.nlm.nih.gov/pubmed/19300589
_version_ 1782165489511825408
author Shirwany, Najeeb A
Payette, Daniel
Xie, Jun
Guo, Qing
author_facet Shirwany, Najeeb A
Payette, Daniel
Xie, Jun
Guo, Qing
author_sort Shirwany, Najeeb A
collection PubMed
description Alzheimer’s disease (AD) is a leading cause of chronic dementia in the US. Its incidence is increasing with an attendant increase in associated health care costs. Since its first description in a patient by Dr. Alois Alzheimer over a century ago, a large body of biomedical literature has established a detailed clinical and molecular profile of this disorder. Amyloid β peptide (Aβ; a 39–42 amino acid molecule) is the major component of senile plaques, the lesions that are one of the pathologic hallmarks of AD (Wong et al 1985). Although many aspects of the biology of amyloid β have been investigated, several fundamental questions about how this peptide causes AD neuropathology remain unanswered. The key question is: How is Aβ toxic to cerebral neurons? Because plaques are extra-neuronal deposits, it is difficult to imagine a structural basis for their toxicity. As an interesting contrast the other pathognomonic feature of AD, neurofibrillary tangles, are intra-axonal structural anomalies that are composed of the hyperphosphorylated microtubule associated (MAP) protein, tau. This review will assess the current thinking that relates to a recent hypothesis of Aβ toxicity. In 1992, Hardy and Higgins reported findings that suggested a new and intriguing possibility. These authors found that Aβ peptides disrupt Ca(2+) homeostasis in neurons and increase intracellular Ca(2+) [Ca(2+)](i). This was corroborated by Mattson and his colleagues who demonstrated that Aβ exposure to human cortical neurons raised [Ca2(+)](i) (Mattson, Cheng et al 1992); (Hardy and Higgins 1992). Finally, Nelson Arispe’s group at the NIH specifically investigated the possibility that Aβ peptides might function like Ca(2+) ion channels (Arispe et al 1993). This and several subsequent studies have laid the foundation for a novel idea: “Aβ peptides are, in part, toxic to neurons because they form aberrant ion channels in neuronal membranes and thereby disrupt neuronal homeostasis”. In this review we shall critically examine this theory in light of classic and contemporary literature.
format Text
id pubmed-2656296
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26562962009-03-19 The amyloid beta ion channel hypothesis of Alzheimer’s disease Shirwany, Najeeb A Payette, Daniel Xie, Jun Guo, Qing Neuropsychiatr Dis Treat Reviews Alzheimer’s disease (AD) is a leading cause of chronic dementia in the US. Its incidence is increasing with an attendant increase in associated health care costs. Since its first description in a patient by Dr. Alois Alzheimer over a century ago, a large body of biomedical literature has established a detailed clinical and molecular profile of this disorder. Amyloid β peptide (Aβ; a 39–42 amino acid molecule) is the major component of senile plaques, the lesions that are one of the pathologic hallmarks of AD (Wong et al 1985). Although many aspects of the biology of amyloid β have been investigated, several fundamental questions about how this peptide causes AD neuropathology remain unanswered. The key question is: How is Aβ toxic to cerebral neurons? Because plaques are extra-neuronal deposits, it is difficult to imagine a structural basis for their toxicity. As an interesting contrast the other pathognomonic feature of AD, neurofibrillary tangles, are intra-axonal structural anomalies that are composed of the hyperphosphorylated microtubule associated (MAP) protein, tau. This review will assess the current thinking that relates to a recent hypothesis of Aβ toxicity. In 1992, Hardy and Higgins reported findings that suggested a new and intriguing possibility. These authors found that Aβ peptides disrupt Ca(2+) homeostasis in neurons and increase intracellular Ca(2+) [Ca(2+)](i). This was corroborated by Mattson and his colleagues who demonstrated that Aβ exposure to human cortical neurons raised [Ca2(+)](i) (Mattson, Cheng et al 1992); (Hardy and Higgins 1992). Finally, Nelson Arispe’s group at the NIH specifically investigated the possibility that Aβ peptides might function like Ca(2+) ion channels (Arispe et al 1993). This and several subsequent studies have laid the foundation for a novel idea: “Aβ peptides are, in part, toxic to neurons because they form aberrant ion channels in neuronal membranes and thereby disrupt neuronal homeostasis”. In this review we shall critically examine this theory in light of classic and contemporary literature. Dove Medical Press 2007-10 /pmc/articles/PMC2656296/ /pubmed/19300589 Text en © 2007 Dove Medical Press Limited. All rights reserved
spellingShingle Reviews
Shirwany, Najeeb A
Payette, Daniel
Xie, Jun
Guo, Qing
The amyloid beta ion channel hypothesis of Alzheimer’s disease
title The amyloid beta ion channel hypothesis of Alzheimer’s disease
title_full The amyloid beta ion channel hypothesis of Alzheimer’s disease
title_fullStr The amyloid beta ion channel hypothesis of Alzheimer’s disease
title_full_unstemmed The amyloid beta ion channel hypothesis of Alzheimer’s disease
title_short The amyloid beta ion channel hypothesis of Alzheimer’s disease
title_sort amyloid beta ion channel hypothesis of alzheimer’s disease
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656296/
https://www.ncbi.nlm.nih.gov/pubmed/19300589
work_keys_str_mv AT shirwanynajeeba theamyloidbetaionchannelhypothesisofalzheimersdisease
AT payettedaniel theamyloidbetaionchannelhypothesisofalzheimersdisease
AT xiejun theamyloidbetaionchannelhypothesisofalzheimersdisease
AT guoqing theamyloidbetaionchannelhypothesisofalzheimersdisease
AT shirwanynajeeba amyloidbetaionchannelhypothesisofalzheimersdisease
AT payettedaniel amyloidbetaionchannelhypothesisofalzheimersdisease
AT xiejun amyloidbetaionchannelhypothesisofalzheimersdisease
AT guoqing amyloidbetaionchannelhypothesisofalzheimersdisease